NCT05710263

Bariatric Embolization Before Sleeve Gastrectomy for Super Obese Patients

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Centre Hospitalier Universitaire, Amiens · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In patients with severe obesity, bariatric surgery provides consistent and long-term weight loss. BMI ≥50kg / m2 is an independent factor of increased morbidity / mortality in bariatric surgery compared with patients weighing less than 50 kg / m2 (1.2% and 0.8%) mainly due to technical difficulties. Preoperative weight loss reduces this morbidity / mortality. Recent studies have shown that blocking blood vessels to a particular portion of the stomach (bariatric or left gastric artery embolization) can temporarily decrease levels of the appetite inducing hormone ghrelin, and result in weight loss. The purpose of this study was to evaluate the safety and effectiveness of the association bariatric embolization before sleeve gastrectomy in super obese patients.

Conditions

• Sleeve Gastrectomy
• Morbid Obesity
• Bariatric Surgery

Interventions

Type	Name	Description
PROCEDURE	bariatric embolization	bariatric or left gastric artery embolization

Timeline

• Start date: 2023-01-10
• Primary completion: 2025-02-13
• Completion: 2025-02-13
• First posted: 2023-02-02
• Last updated: 2025-02-17